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It is nearly 4 years since genome-wide association studies 
identified common variants in the human fat mass and 
obesity  associated  (FTO)  gene  to  be  associated  with 
normal  variation  in  body  mass  index  (BMI)  in  several 
adult  population  studies  [1].  The  finding  was  the  first 
robust identification of a common variant with BMI and 
obesity, and the ‘fat gene’ story made scientific and media 
headlines.
The  same  studies  in  human  populations  established 
that  the  effect  on  BMI  was  driven  entirely  through 
adiposity, as opposed to skeletal or lean tissue mass, and 
that the effect on BMI was not present at birth, was fully 
present by the age of 7 years, and seemed to be stable 
throughout adulthood [1]. But to use the analogy of a 
jigsaw  puzzle,  these  observations  represented  ‘sky’ 
pieces - good to find but of limited use in finding the next 
piece. The next move was hindered by the fact that the 
gene had no obvious known role in metabolism, appetite 
control, or activity levels and the function of the protein 
was  poorly  characterized.  Scientists  could  not  even  be 
sure they had the right gene - genome-wide association 
studies identify DNA variants, not genes, that are asso-
ciated with traits and, although the associated variants 
are in intron 1 of FTO, they are close to the 5’ end of the 
gene encoding the retinitis pigmentosa GTPase regulator-
interacting protein 1-like protein (RPGRIP1L). If a variant 
is ‘in’ the FTO gene, it does not necessarily mean that it 
‘acts through’ the FTO gene.
A few more pieces to the puzzle were found in the first 
year following the identification of the FTO association 
with  BMI.  Studies  described  the  FTO  protein  as  a 
2-oxoglutarate-dependent  enzyme  that  localizes  to  the 
nucleus, found that it is widely expressed but especially 
so in the hypothalamus (in humans and mice), and that 
expression in the arcuate nucleus of the hypothalamus 
(the most critical component to appetite control in the 
brain) was lower in fasting than in freely feeding mice [2].
Two recent studies have now provided some ‘corner’ 
pieces to the FTO puzzle. Church et al. [3] have created 
and  characterized  a  mouse  model  that  most  closely 
resembles the human phenotype and Sovio et al. [4] have 
performed the most comprehensive assessment of how 
the  association  of  FTO  with  BMI  changes  throughout 
childhood  (as  it  must  given  the  lack  of  association  at 
birth and strong association by age 7 years).
Association between variation in the FTO gene and 
BMI-related traits in childhood
Children’s  weight  corrected  for  their  height  follows  a 
distinct pattern, peaking at around the age of 9 months to 
1 year - the adiposity peak - and reaching a trough at 
approximately 5 years of age - the adiposity rebound - 
before increasing again steadily before puberty (Figure 1). 
The recent study from Sovio et al. [4] provides compelling 
evidence  that  the  minor  allele  in  FTO  (called  the  ‘fat’ 
allele)  is  associated  with  children  emerging  from  their 
adiposity trough earlier than the major ‘thin’ allele. They 
also show, consistent with the original findings, that the 
minor allele is associated with increased BMI by the age 
of 7 years [4]. The earlier adiposity rebound was consis-
tent across six studies (cited in [4]) that had measured 
children repeatedly between birth and puberty. Intriguingly, 
the  same  study  [4]  reported  an  inverse  association  at 
adiposity peak - the minor ‘fat’ allele was associated with 
lower BMI than the major ‘thin’ allele, not higher BMI as 
would be expected - although the statistical confidence of 
this  finding  was  much  less  than  the  association  with 
adiposity rebound.
Maturation
A recent genome-wide association study showed that the 
minor FTO ‘fat’ allele was associated with earlier sexual 
maturation  in  girls  -  the  allele  was  associated  with  an 
average  0.5  months  earlier  age  at  menarche  [5].  This 
finding was expected given the well known correlation 
between increased adiposity and earlier age at puberty in 
girls. The expectation is that an effect with puberty will 
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© 2011 BioMed Central Ltdalso be seen in boys, although the effect may not be as 
strong  given  the  weaker  correlation  between  adiposity 
and puberty in boys.
Appetite, activity or metabolism?
Assessing the mechanism by which variants in the FTO 
gene  influence  adiposity  is  extremely  challenging.  The 
full effects of the variant are present by age 7 years in 
humans  and  by  equivalent  stages  of  maturity  in  mice. 
This  immediately  makes  it  very  difficult  to  study  the 
effects on appetite, activity, or metabolism because fatter 
individuals  will  eat,  behave,  and  metabolize  differently 
from  the  way  thinner  individuals  do  simply  as  a 
consequence of being more overweight. Human studies 
assessing  the  association  between  FTO  alleles  and 
appetite  tried  to  overcome  this  problem  by  correcting 
statistics  for  BMI,  but  were  still  hindered  by  the  well 
known phenomenon that overweight individuals tend to 
under-report what they eat.
Church et al. [3] tested a wide range of measures in 
mice with extra copies of the FTO gene and corrected 
their statistical associations for any differences in BMI. A 
picture emerged that mice with three or four copies of 
the FTO gene eat more for their body weight than mice 
with  two  copies  of  the  gene.  This  energy  intake  effect 
predominated over alterations in metabolism and activity, 
which  confirmed  that  the  ‘fat  allele’  phenotype  was 
related to gain of function of FTO. Previous studies in 
mice showed that whole-body knockout or a dominant 
mutation in FTO resulted in thinner, smaller mice [6,7]. 
The  predominant  phenotype  in  these  ‘loss  of  function’ 
models seemed to be faster metabolism, so further work 
in animal models is needed.
There  is  another  important  piece  of  the  FTO  jigsaw 
missing.  If  geneticists  could  identify  a  human  FTO 
mutation that resulted in a severe obesity-related pheno-
type, it could provide a fundamental part of the picture. 
Such patients and their relatives could be studied in detail 
to  elucidate  the  underlying  mechanisms.  Two  studies 
have tried to identify individuals with rarer, more pene-
trant FTO alleles. One [8] identified a mutation so severe 
that it resulted in an autosomal recessive lethal disorder 
with multiple defects, including severe postnatal growth 
retardation  and  a  maximum  survival  of  2.5  years.  The 
second  [9]  sequenced  lean  and  obese  individuals  and 
identified several rare variants that resulted in some in 
vitro  functional  defects  to  the  protein.  However,  the 
study [9] did not conclusively establish causality through 
Figure 1. BMI throughout childhood and adulthood in individuals of different FTO genotypes. The A allele genotype is the minor ‘fat’ allele 
AT rs9939609. The figure was adapted from Sovio et al. [4] and is based on real association data in childhood and a schematic of the association 
in adulthood (BP, blood pressure). Boxes describe associations with the minor ‘fat’ allele and stars are indicative of the statistical confidence of the 
association.
30
25
20
Earlier 
menarche
in girls
****
Lower BMI
at adiposity 
peak
*
Increased
i k f t 2
18
17
20 *
BMI 
(kg/m2)
Increased
BMI
******
Altered
metabolic
traits (lipids,
glucose, insulin
BP)
****
risk of type 2
diabetes
******
16
15
Earlier 
adiposity
15
0   1   2   3   4   5   6   7   8   9   10   12
Age (years)
Adulthood
p y
rebound
*****
Frayling and Ong Genome Biology 2011, 12:104 
http://genomebiology.com/2011/12/2/104
Page 2 of 3co-segregation, and variants occurred in obese as well as 
lean individuals. It remains highly plausible that nature 
has provided scientists with a more relevant FTO mono-
genic phenotype to study, but the patients remain to be 
found.
In summary, there is still much to learn about the FTO 
gene and its product, but the pieces are starting to come 
together.  None  of  these  fascinating  biological  studies 
would  have  been  possible  without  the  initial  genome-
wide association studies [1].
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